Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress

NCT04728698 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Replaced by a different protocol.

Conditions

Covid19
ARDS

Interventions

DRUG: COVI-MSC
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.